Skip to main content
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ETON ISIN · US29772L1089 US Manufacturing
Filings indexed 358 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country US United States of America
Listing US ETON

About Eton Pharmaceuticals, Inc.

https://etonpharma.com/

Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The company's strategy involves sourcing, acquiring, and developing therapies to serve small, underserved patient populations. Eton manages the complete drug development lifecycle, from navigating clinical trials and the regulatory approval process to bringing the final products to market. It actively seeks meaningful therapies from a global network of partners to build a diversified portfolio of treatments.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings
2026-05-19 English
FORM 10-Q
Interim / Quarterly Report
2026-05-14 English
FORM 8-K
Regulatory Filings
2026-05-14 English
8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer)
Regulatory Filings
2026-04-27 English
8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer)
Regulatory Filings
2026-04-16 English
10-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer)
Annual Report FY 2025
2026-03-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.